Onyx Healthcare (ROCO:6569) Shares Outstanding (EOP): 39 Mil (As of Dec. 2025)


ROCO:6569 Onyx Healthcare Inc ROCO:6569
75 GF Score
Price NT$106.50
GF Value NT$121.39
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Onyx Healthcare Shares Outstanding (EOP)?

Onyx Healthcare ROCO:6569 75 Shares Outstanding (EOP) is 39 Mil as of Dec. 2025. GuruFocus rates ROCO:6569 with a GF Score™ of 75/100 and a GF Value™ of NT$121.39 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Onyx Healthcare's shares outstanding for the quarter that ended in Dec. 2025 was 39 Mil.

Onyx Healthcare's quarterly shares outstanding stayed the same from Sep. 2025 (39 Mil) to Dec. 2025 (39 Mil).

Onyx Healthcare's annual shares outstanding increased from Dec. 2024 (39 Mil) to Dec. 2025 (39 Mil). It means Onyx Healthcare issued new shares from Dec. 2024 to Dec. 2025 .


Onyx Healthcare  (ROCO:6569) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Onyx Healthcare Shares Outstanding (EOP) Related Terms


Onyx Healthcare Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Onyx Healthcare's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onyx Healthcare Shares Outstanding (EOP) Chart

Onyx Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.27 38.25 38.54 38.63 39.07

Onyx Healthcare Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.63 39.01 39.01 39.07 39.07

ROCO:6569 vs VEEV, BTSG, TEM: Shares Outstanding (EOP) Comparison

For the Health Information Services subindustry, Onyx Healthcare's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Onyx Healthcare Shares Outstanding (EOP) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Onyx Healthcare's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Onyx Healthcare's Shares Outstanding (EOP) falls into.


ROCO:6569
75GF Score
Onyx Healthcare Inc ROCO:6569
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onyx Healthcare Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 39 Mil mean?
Onyx Healthcare (ROCO:6569) has a Shares Outstanding (EOP) of 39 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on Onyx Healthcare and its competitors.
Is Onyx Healthcare's Shares Outstanding (EOP) too high?
Onyx Healthcare's current Shares Outstanding (EOP) is 39 Mil. Overall, Onyx Healthcare has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Onyx Healthcare's Shares Outstanding (EOP) compare to VEEV and BTSG?
Onyx Healthcare's Shares Outstanding (EOP) of 39 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Healthcare Providers & Services company?
A good Shares Outstanding (EOP) depends on the Healthcare Providers & Services industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Onyx Healthcare and its competitors. Onyx Healthcare's current Shares Outstanding (EOP) is 39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Onyx Healthcare (ROCO:6569) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$121.39, compared to a current price of NT$106.50 — trading 12.3% below its estimated fair value. The current Shares Outstanding (EOP) is 39 Mil. Onyx Healthcare's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Onyx Healthcare (ROCO:6569), the current Shares Outstanding (EOP) is 39 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Onyx Healthcare (ROCO:6569) Overvalued in 2026?

Based on GuruFocus' analysis, Onyx Healthcare stock appears to be undervalued. The current stock price of NT$106.50 is trading 12.3% below its estimated GF Value™ of NT$121.39. GuruFocus considers Onyx Healthcare to be Modestly Undervalued.

Key valuation signals for ROCO:6569:

  • Shares Outstanding (EOP): 39 Mil
  • GF Value™: NT$121.39 vs. price of NT$106.50 (12.3% below fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Onyx Healthcare Business Description

Address No. 135, Lane 235, Baoqiao Road, 4th Floor, Xindian District, New Taipei, TWN, 231028
Onyx Healthcare Inc is engaged in designing, manufacturing, and trading of medical computers and peripherals. The company provides medical products such as AI Ready Medical PC and Tablet, Medical PC & Monitor for Digital OR (ACCEL), Telemedicine, Medical Cart Computer(Venus), Medical Power Panel PC (Mini Venus), Power Bank (UPower), Battery Management System (ORION), Mobile Medical Tablet (MD), Professional Medical All in One PC (ZEUS), etc. It operates in Taiwan, the United States, Europe, and Other countries and generates maximum revenue from Taiwan.
75GF Score

Get the complete analysis for ROCO:6569

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$106.50
Price
NT$121.39
GF Value